1 February 2017 - Deborah Wilkes
Archived
Sanofi Consumer Healthcare plans to launch OTC versions of the allergy medicine Xyzal (levocetirizine dihydrochloride) in the US in "Spring 2017".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.